Objective-The purpose of this study was to explore communication barriers as independent predictors and potential mediators of variation in clinical recognition of diabetic peripheral neuropathy (DPN).
Research Design and Methods
The setting for this study was Kaiser Permanente Northern California (KPNC), a large integrated health care delivery system serving more than 3 million people. This study was conducted as part of the Diabetes Study of Northern California (DISTANCE) and its ancillary, the Diabetes & Aging Study. DISTANCE surveyed a race-stratified, random sample of patients with diabetes to understand social disparities in diabetes care and outcomes. 15 Data from DISTANCE were linked to clinical and administrative data from the Kaiser Permanente Diabetes Registry of Northern California, a database of Kaiser Permanente members diagnosed with diabetes since 1971 and the EHR at KPNC. Among the 20,188 KPNC members who responded to the DISTANCE survey (response rate 62%), the sample was restricted to the five largest race/ethnicity subgroups (i.e., those who self-identified as African American or black, white, Chinese, Latino or Hispanic, or Filipino). Respondents with any lower extremity amputation were excluded due to the high probability that it was influenced by the condition of primary interest, DPN. 1, 2 Among the remaining 15,847 respondents, 12,681 or 80% answered a question regarding the presence of DPN symptoms and their responses will be the focus of this analysis. This study focused on the 4,436 adult diabetes patients who reported having symptoms consistent with DPN on the survey.
Outcome measure
The primary outcome of interest for this study was clinical documentation of DPN, defined as the presence of at least one inpatient or two outpatient diagnoses for peripheral neuropathy (ICD9: 356.0, 356.9, 357.2) in the medical record during the 24 months before or after the survey administration date. 16 Also included were ICD 9 codes for related conditions that may mimic DPN in symptomatology, such as neuralgic amyotrophy, lesion of the plantar nerve, and neuralgia neuritis and radiculitis unspecified (ICD9: 250. 4, 729.2) . This dichotomous measure served as the primary outcome for the regression models.
Measures of Communication Barriers
Barriers to patient-provider communication were assessed in four ways. First, the behavior of discussing pain with one's doctor was represented by a survey question asking whether the patient discussed pain with their doctor in the prior 12 months. The question did not refer to DPN specifically, but to pain of any kind. Seventy one percent of patients with symptoms answered the following question: "During the past 12 months, have you ever discussed problems with pain with your doctor or health care provider?" Second, an indicator of whether the patient reported difficulty communicating in English was included. This was measured based on a validated question asking if the patient had difficulty speaking or understanding English: always, often, sometimes, rarely or never). Eighty-five percent of patients with symptoms answered this question. Patients who answered always, often, or sometimes were categorized as having LEP.
Third, health literacy was assessed based on a previously validated 3-item brief health literacy scale. From this scale, a single item, "How confident are you filling out medical forms by yourself?", was used to assess health literacy. [17] [18] [19] [20] [21] Specifically, patients were classified as having limited health literacy if they reported being somewhat, a little or not at all confident and health literate if they reported being quite a bit or extremely confident in their ability to understand health information. Previous publications using our study population have demonstrated the utility and validity of this scale in predicting outcomes that would be expected to be associated with inadequate health literacy. 17, 19, [21] [22] [23] [24] Quality of patient-provider communication was assessed using the 4-point communication composite score for the well-known Consumer Assessment of Healthcare Providers and Systems (CAHPS) version 2.0 survey, 25 based on patient responses to at least two out of four questions regarding the frequency with which their provider 1) listened carefully to what they had to say, 2) explained things in a way they could understand, 3) showed respect for what the patient had to say or 4) spent enough time with the patient. These questions were combined into a summary score with a best possible value of 100 and a minimum value of 0. For the 77% of subjects that answered these questions, we created a dichotomous indicator of communication quality to indicate optimal communication (i.e., score of 100) or suboptimal communication (i.e., score < 100). Three previous publications have demonstrated the utility and validity of these items and dichotomization of responses as worded in the DISTANCE survey in predicting outcomes that would be expected to be associated with patient-provider communication. [17] [18] [19] Race/Ethnicity Race/ethnicity was the exposure of interest. Racial and ethnic subgroups were identified using self-reported categories from the DISTANCE survey: Chinese, African American, Latino/Hispanic, white or Filipino. Other racial and ethnic subgroups, including those reporting mixed race, were excluded due to small sample size.
Potential mediators
Clinical and Demographic Charcateristics-The frequency of DPN symptoms was assessed using a previously validated, single item question in the DISTANCE Survey: "Over the past 4 weeks, how often have you had pins and needles, numbness, burning or a tingling sensation in both your feet?"Response options regarding symptom frequency were: 5 to 7 days a week; 3 to 4 days a week; 1 to 2 days a week; 1 to 3 days a month; or never or rarely. The statistical models predicting the likelihood of a diagnosis were restricted to those who reported having symptoms at least one day per month.
Clinical status was classified based on a combination of self-report and EHR data. Several measures of diabetes severity that are known risk factors for peripheral neuropathy were included:self-reported duration of diabetes in years (<5, 5-9, 10 years or more), an indicator for whether the last observed (prior to survey date) hemoglobin A1c (HbA1c) was greater than 9%, and evidence of any pharmacy dispensing of insulin. We controlled for BMI (underweight<18.5, overweight=25-30; obese>30) as recorded in the EHR, using normal weight (BMI=18. as the referent group. Also included was an indicator for whether the total number of outpatient visits was above or below the median for all patients in the cohort to account for opportunities for diagnostic assessment and for possible competing demands for health care services.
Based on previous reports of a high degree of concurrent chronic pain and depression among patients with diabetes in our own 5, 6 and other 26 studies, an indicator for the presence of depressive symptoms reported in the survey was also included in the model. Depressive symptoms were defined as having a score of 10 or greater on the previously validated 8-item Patient Health Questionnaire depression scale (PHQ-8). 27 Patients were classified into three age groups (<50, 50-65, 65+ years), sex, and educational achievement based on self-report (<high school graduate, high school graduate or equivalent, some college, college graduate).
Statistical Analysis
Baseline differences in sociodemographic and clinical characteristics for patients with and without DPN symptoms were evaluated using t tests and chi-square tests. Among the subset reporting symptoms, the likelihood of clinical documentation of DPN as described above was assessed. Given that clinical documentation of DPN is not a rare event, we estimated a modified Poisson regression model to evaluate predictors of this dichotomous outcome. 28 The likelihood ratio statistic was used to assess model fit and multiple imputation to address missing covariates due to survey non-response to several categorical measures (e.g., difficulty understanding or speaking English). 29 The multiple imputed data set (20 imputations) was created using the multivariate normal model and Markov Chain Monte Carlo approach. Variables included in the model were the above described measures of patient demographic, clinical characteristics, and frequency of contact with the health care system.
Crude differences in detection by race and ethnicity were first evaluated. Next each of the communication barriers was separately added to the basic model to evaluate them as mediators of the race/ethnic differences and/or independent predictors of the outcome. Due to a high degree of correlation between the communication measures, we did not include them together in a single model. The impact of the inclusion of these measures to the basic model was assessed through evaluation of changes in the effect size and statistical significance of the other covariates to evaluate whether the communication measures explained variation in fixed attributes (i.e., race/ethnicity). 30 Model fit was assessed using the Information Criterion. 31 All statistical analyses were conducted in SAS v9.3. 32 This study was approved by the Institutional Review Board at Kaiser Foundation Research Institute.
Results

Characteristics of Respondents with and without DPN Symptoms
Our cohort of 12,681 adult diabetes patients included: 31% self-identified as white, 8% Chinese, 22% African American or black, 24% Latino and 15% Filipino ( Table 2) .
Communication Barriers as Independent Predictors of Variation
The results of our evaluation of the separate communication factors as independent predictors and as potential mediators of racial and ethnic differences are presented in Table  3 . 
Discussion
In a diverse cohort of diabetes patients, 35% (N=4,436) reported having symptoms indicating distal diabetic peripheral neuropathy. Diabetes patients with DPN symptoms had higher BMI and more outpatient visits relative to those without symptoms, which was similar to a previous study in a similar setting. 33 DPN was clinically documented in the EHR for nearly half of patients who reported symptoms. Chinese, Filipino, and Latino were significantly less likely to have clinical documentation of DPN.
Low English language proficiency was independently associated with the absence of clinical documentation, as was not talking with one's doctor about pain. While English proficiency slightly attenuated racial and ethnic differences in diagnosis, neither of these communication factors fully explained differences in DPN documentation by race/ethnicity. At the time these data were collected, interpreter and translation services were available in this setting, including in person services, phone services, and translated educational materials. However, additional services and programs related to the qualification of bilingual staff and the implementation of real-time interpreter services via remote video have been implemented in recent years. 34 In addition to identifying substantive race/ethnic differences, these findings suggest that some, but not all communication factors may influence the likelihood of clinical recognition of DPN across subgroups. For example, we did not find an association between patientreported communication quality and clinical documentation of DPN. A previous study using data from the DISTANCE survey found a positive association between patient-provider communication and medication adherence among diabetes patients. 19 Our findings may suggest that the quality of communication has a different and potentially larger impact postdiagnosis than on the likelihood of clinical recognition of DPN. 19 Clinical risk factors such as symptom frequency and the frequency of physician visits were more strongly associated with the outcome, suggesting that diseases that require a patient to tell the story may be under-detected relative to those that manifest in ways that are obvious to the clinician (e.g., physical signs).
This may be the first study to show differences in rates of clinical recognition of DPN by race and ethnicity. In particular, our finding of substantially lower rates of clinical recognition of DPN among Chinese, Latino and Filipino patients was enabled by the highly diverse nature of the DISTANCE cohort. However, the included communication barriers, some of which were modestly predictive, failed to explain observed differences in diagnosis by patient attributes of race/ethnicity. Moreover, no evidence of interaction effects was found, suggesting there may be other, unobserved factors that account for the social or cultural differences in detection of DPN.
Several study limitations should be taken into account. Causal inferences are not possible given the cross sectional design. The absence of a recorded clinical diagnosis in the EHR may reflect a failure to record, but not necessarily a failure to detect diabetic peripheral neuropathy. This measurement error may have caused us to underestimate rates of detection, but should not bias our estimates of the differential effect of social factors and communication on the likelihood of having a recorded diagnosis if failure to diagnose is similar across patient characteristics. While it is possible that some patients reporting DPNlike symptoms actually had other co-occurring pain conditions such as arthritis, the similarity of our symptom-based prevalence estimate to other reports of DPN suggest that such misattribution was rare. In addition, a conservative approach of including several additional ICD 9 codes to cover conditions that may have a similar presentation to DPN was employed. Similarly, DPN could be present in the absence of any patient awareness (e.g., numbness only) and this may impact the likelihood of clinical recognition and may differ by race/ethnicity.
Multiple imputation was used to account for missing data with the knowledge that the likelihood of missing covariates may have been related to patient characteristics and the likelihood of the outcome. These results were robust to sensitivity analyses that included modeling in a missing category and use of complete case analysis. However, the analysis did not control for possible non-response bias in communication related questions in the DISTANCE survey in which patients who elected not to answer questions about communication may have been systematically different in statistically significant ways. In addition, patients may have received a diagnosis outside our window of observation of two years before and after the symptom report. However, reliance on an EHR and the stable nature of this Kaiser membership make it less likely that diagnoses were missed.
Finally, because the data used were not explicitly collected for the purpose of identifying predictors of DPN, the models could not directly specify the temporal relationships between the communication variables (e.g., communicating with one's doctor about pain) and the diagnosis of DPN.
Conclusions
Health care costs attributed to DPN are estimated to be between $5 and $15 billion per year, accounting for nearly one-third of all diabetes related costs. 1 While DPN is not curable, progression can be slowed through improved glycemic control 3, 35 and long term impact may be reduced through the effective treatment of symptoms. 36, 37 Untreated symptoms are associated with higher health services use and costs among patients with DPN. 2, 3, 36 In addition, patients with distal DPN are at a much greater risk of lower extremity infection and amputation. 38 These findings suggest that strategies to improve DPN recognition and treatment should be sensitive to both communication barriers and potential under-recognition of DPN among Chinese, Latinos and Filipino patients. Health systems should explore opportunities to reduce gaps in communication, specifically enhancing the propensity of patients to discuss pain, and alleviating language barriers between patients and providers. Competing demands in the clinic setting may impede efforts to collect information about DPN or its symptoms during routine visits. 39 To address this challenge, the health care system in which this study was conducted recently instituted routine screening of diabetes patients for DPN by medical assistants while patients wait for a doctors' appointment. Alternatively, several studies have reported success in the use of patient-focused technology (e.g., interactive voice response, 
